Baillie Gifford & Co. Sells 20,492 Shares of Aehr Test Systems (NASDAQ:AEHR)

Key Points

• Baillie Gifford & Co. reduced its stake in Aehr Test Systems by 1.0%, maintaining approximately 6.73% ownership worth $14.60 million as of the latest SEC filing.
• Aehr Test Systems shares recorded a 2.0% increase, with a current market cap of $647.20 million and a 12-month price range between $6.27 and $23.00.
• Insider activity revealed a combined sale of 30,995 shares by company executives in the past quarter, indicating potential shifts in internal confidence regarding the stock.

Baillie Gifford & Co. lowered its stake in shares of Aehr Test Systems (NASDAQ:AEHR - Free Report) by 1.0% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,003,067 shares of the semiconductor company's stock after selling 20,492 shares during the period. Baillie Gifford & Co. owned approximately 6.73% of Aehr Test Systems worth $14,602,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently modified their holdings of the company. State of Wyoming bought a new position in shares of Aehr Test Systems during the 4th quarter worth approximately $67,000. Headlands Technologies LLC acquired a new position in shares of Aehr Test Systems during the 4th quarter worth $103,000. GAMMA Investing LLC raised its holdings in shares of Aehr Test Systems by 1,753.1% during the 1st quarter. GAMMA Investing LLC now owns 7,079 shares of the semiconductor company's stock worth $52,000 after buying an additional 6,697 shares in the last quarter. Mariner LLC acquired a new position in Aehr Test Systems in the 4th quarter worth about $180,000. Finally, Bayesian Capital Management LP acquired a new stake in shares of Aehr Test Systems in the fourth quarter valued at about $185,000. Institutional investors and hedge funds own 69.69% of the company's stock.

Insiders Place Their Bets

In other news, Director Rhea J. Posedel sold 18,000 shares of the stock in a transaction on Tuesday, July 22nd. The stock was sold at an average price of $19.83, for a total transaction of $356,940.00. Following the transaction, the director directly owned 71,163 shares of the company's stock, valued at $1,411,162.29. This represents a 20.19% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Laura Oliphant sold 5,000 shares of the stock in a transaction on Friday, July 25th. The shares were sold at an average price of $21.50, for a total value of $107,500.00. Following the transaction, the director directly owned 7,665 shares in the company, valued at $164,797.50. The trade was a 39.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 30,995 shares of company stock valued at $552,185. Insiders own 6.20% of the company's stock.

Aehr Test Systems Trading Down 2.3%

Shares of AEHR traded down $0.44 on Wednesday, reaching $18.34. 309,771 shares of the company's stock traded hands, compared to its average volume of 1,125,609. The stock's 50 day simple moving average is $13.29 and its two-hundred day simple moving average is $10.88. Aehr Test Systems has a 52-week low of $6.27 and a 52-week high of $23.00. The stock has a market cap of $545.98 million, a PE ratio of -141.23 and a beta of 2.29.

Aehr Test Systems (NASDAQ:AEHR - Get Free Report) last posted its earnings results on Tuesday, July 8th. The semiconductor company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. Aehr Test Systems had a negative return on equity of 0.15% and a negative net margin of 6.63%. The firm had revenue of $14,100 billion for the quarter, compared to the consensus estimate of $14.83 million. Analysts forecast that Aehr Test Systems will post 0.1 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded Aehr Test Systems to a "sell" rating in a report on Tuesday, May 13th.

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.